3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
24
Stomach Neoplasms
10
Pancreatic Neoplasms
10
Rectal Neoplasms
9
Colonic Neoplasms
9
Adenocarcinoma Of Esophagus
8
Esophageal Neoplasms
7
Urinary Bladder Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
5
Adenocarcinoma
5
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Cholangiocarcinoma
4
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Carcinoma
3
Ovarian Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Hepatoblastoma
2
Gallbladder Neoplasms
2
Biliary Tract Neoplasms
2
Anus Neoplasms
2
Advanced Solid Tumors
2
Uterine Cervical Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Interventions
durvalumab
2
Tretinoin
2
Paclitaxel
2
Carboplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Pemetrexed
1
MK 2206
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Fluorouracil
×
30 days
×
Clear all
No trials found.